{"entity":{"type":"insider","cik":"0001758376","url":"/insider/0001758376","json_url":"/insider/0001758376.json","name":"Peisert Daniel A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":9,"first":"2019-03-18","last":"2023-09-13","span_basis":"filed_date"},"name_variants":[{"name":"Peisert Daniel A.","source":"filing","n_filings":9,"first_seen":"2019-03-18","last_seen":"2023-09-13"}],"transactions":[{"id":8073299,"accession":"0001104659-23-100550","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-100550","line_url":"/filing/0001104659-23-100550#line-2","is_derivative":false,"issuer_cik":"0001758376","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001758376","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31121.0,"shares_display":"31,121","price_per_share":2.9701,"price_display":"2.97","price_state":"stated","total_value":92432.4821,"total_display":"92,432.48","shares_owned_after":324939.0,"shares_owned_after_display":"324,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":8073294,"accession":"0001104659-23-100550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-100550","line_url":"/filing/0001104659-23-100550#line-1","is_derivative":false,"issuer_cik":"0001758376","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001758376","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127281.0,"shares_display":"127,281","price_per_share":3.0403,"price_display":"3.04","price_state":"stated","total_value":386972.4243,"total_display":"386,972.42","shares_owned_after":356060.0,"shares_owned_after_display":"356,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-13","scope":"insider"},{"id":6989446,"accession":"0001758376-22-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001758376-22-000005","line_url":"/filing/0001758376-22-000005#line-1","is_derivative":false,"issuer_cik":"0001758376","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001758376","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26391.0,"shares_display":"26,391","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":92368.5,"total_display":"92,368.50","shares_owned_after":158402.0,"shares_owned_after_display":"158,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-13","scope":"insider"},{"id":6689107,"accession":"0001758376-22-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001758376-22-000004","line_url":"/filing/0001758376-22-000004#line-1","is_derivative":false,"issuer_cik":"0001758376","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001758376","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34518.0,"shares_display":"34,518","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":120813.0,"total_display":"120,813.00","shares_owned_after":184793.0,"shares_owned_after_display":"184,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-05","filed_date":"2022-04-07","scope":"insider"},{"id":4916870,"accession":"0001808665-21-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001808665-21-000054","line_url":"/filing/0001808665-21-000054#line-1","is_derivative":false,"issuer_cik":"0001758376","issuer_name":"Assertio Holdings, Inc.","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001758376","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15909.0,"shares_display":"15,909","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":24499.86,"total_display":"24,499.86","shares_owned_after":89655.0,"shares_owned_after_display":"89,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-24","scope":"insider"},{"id":8280059,"accession":"0001005201-19-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005201-19-000126","line_url":"/filing/0001005201-19-000126#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.7259,"price_display":"0.73","price_state":"stated","total_value":7259.0,"total_display":"7,259.00","shares_owned_after":74873.0,"shares_owned_after_display":"74,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-12","scope":"insider"},{"id":8280055,"accession":"0001005201-19-000107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005201-19-000107","line_url":"/filing/0001005201-19-000107#line-2","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":15200.0,"total_display":"15,200.00","shares_owned_after":52655.0,"shares_owned_after_display":"52,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-20","scope":"insider"},{"id":8280051,"accession":"0001005201-19-000107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005201-19-000107","line_url":"/filing/0001005201-19-000107#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":5800.0,"total_display":"5,800.00","shares_owned_after":56655.0,"shares_owned_after_display":"56,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-20","scope":"insider"},{"id":9214042,"accession":"0001005201-19-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005201-19-000105","line_url":"/filing/0001005201-19-000105#line-2","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17100.0,"shares_display":"17,100","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":26847.0,"total_display":"26,847.00","shares_owned_after":41356.0,"shares_owned_after_display":"41,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-20","scope":"insider"},{"id":9214041,"accession":"0001005201-19-000105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005201-19-000105","line_url":"/filing/0001005201-19-000105#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2900.0,"shares_display":"2,900","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":4466.0,"total_display":"4,466.00","shares_owned_after":24256.0,"shares_owned_after_display":"24,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-20","scope":"insider"},{"id":8666225,"accession":"0001005201-19-000097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005201-19-000097","line_url":"/filing/0001005201-19-000097#line-2","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17100.0,"shares_display":"17,100","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":26847.0,"total_display":"26,847.00","shares_owned_after":40356.0,"shares_owned_after_display":"40,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-12","scope":"insider"},{"id":8666222,"accession":"0001005201-19-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005201-19-000097","line_url":"/filing/0001005201-19-000097#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":2926.0,"total_display":"2,926.00","shares_owned_after":23256.0,"shares_owned_after_display":"23,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-12","scope":"insider"},{"id":8199652,"accession":"0001005201-19-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005201-19-000044","line_url":"/filing/0001005201-19-000044#line-2","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.178,"price_display":"4.18","price_state":"stated","total_value":20890.0,"total_display":"20,890.00","shares_owned_after":20356.0,"shares_owned_after_display":"20,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-14","filed_date":"2019-03-18","scope":"insider"},{"id":8199644,"accession":"0001005201-19-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005201-19-000044","line_url":"/filing/0001005201-19-000044#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001758376","owner_name":"Peisert Daniel A.","owner_url":"/insider/0001758376","role":"Officer (SVP and CFO)","officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.179,"price_display":"4.18","price_state":"stated","total_value":4179.0,"total_display":"4,179.00","shares_owned_after":21356.0,"shares_owned_after_display":"21,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-14","filed_date":"2019-03-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001808665","name":"Assertio Holdings, Inc.","url":"/issuer/0001808665","role":"Director, Officer (President & CEO)","n_filings":4,"first_seen":"2021-05-24","last_seen":"2023-09-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001005201","name":"Assertio Therapeutics, Inc","url":"/issuer/0001005201","role":"Officer (SVP and CFO)","n_filings":5,"first_seen":"2019-03-18","last_seen":"2019-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001758376","retrieved_at":"2026-08-21T08:00:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}